カテゴリー： QYResearch, 世界, 医療/バイオ

DTPワクチンのグローバル市場2023年：百日咳、ジフテリア、破傷風

◆英語タイトル：Global DTP Vaccine Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA8747）◆商品コード：QYR23MA8747
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：103
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界のDTPワクチン市場について調査・分析し、世界のDTPワクチン市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（百日咳、ジフテリア、破傷風）、用途別セグメント分析（病院、防疫所、保健所）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、SANOFI PASTEUR、NOVARTIS、Vaxelis、GSK、Serum Institute of India、Johnson & Johnson、Merck Sharp & Dohme Corp、Seqirus、Pfizer、Astrazeneca、astellas、Emergent BioSolutions Inc、WALVAX、Wuhan Institute of Biological Products Co.,Ltd.、Chengdu Institute of Biological Products Co.,Ltd.などが含まれています。世界のDTPワクチン市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、DTPワクチン市場規模を推定する際に考慮しました。

・DTPワクチン市場の概要
- 製品の定義
- DTPワクチンのタイプ別セグメント
- 世界のDTPワクチン市場規模：タイプ別分析（百日咳、ジフテリア、破傷風）
- DTPワクチンの用途別セグメント
- 世界のDTPワクチン市場規模：用途別分析（病院、防疫所、保健所）
- 世界のDTPワクチン市場規模予測（2018年-2029年）
- DTPワクチンの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- DTPワクチン市場の競争状況およびトレンド

・DTPワクチンの地域別市場規模
- 北米のDTPワクチン市場規模（2018年-2029年）
- アメリカのDTPワクチン市場規模（2018年-2029年）
- ヨーロッパのDTPワクチン市場規模（2018年-2029年）
- アジア太平洋のDTPワクチン市場規模（2018年-2029年）
- 中国のDTPワクチン市場規模（2018年-2029年）
- 日本のDTPワクチン市場規模（2018年-2029年）
- 韓国のDTPワクチン市場規模（2018年-2029年）
- インドのDTPワクチン市場規模（2018年-2029年）
- オーストラリアのDTPワクチン市場規模（2018年-2029年）
- 中南米のDTPワクチン市場規模（2018年-2029年）
- 中東・アフリカのDTPワクチン市場規模（2018年-2029年）

・タイプ別セグメント：百日咳、ジフテリア、破傷風
- 世界のDTPワクチンのタイプ別販売量（2018年-2023年）
- 世界のDTPワクチンのタイプ別売上（2018年-2023年）
- 世界のDTPワクチンのタイプ別価格

・用途別セグメント：病院、防疫所、保健所
- 世界のDTPワクチンの用途別販売量（2018年-2023年）
- 世界のDTPワクチンの用途別売上（2018年-2023年）
- 世界のDTPワクチンの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
SANOFI PASTEUR、NOVARTIS、Vaxelis、GSK、Serum Institute of India、Johnson & Johnson、Merck Sharp & Dohme Corp、Seqirus、Pfizer、Astrazeneca、astellas、Emergent BioSolutions Inc、WALVAX、Wuhan Institute of Biological Products Co.,Ltd.、Chengdu Institute of Biological Products Co.,Ltd.

・産業チェーンと販売チャネルの分析
- DTPワクチン産業チェーン分析
- DTPワクチンの主要原材料
- DTPワクチンの販売チャネル
- DTPワクチンのディストリビューター
- DTPワクチンの主要顧客

・DTPワクチン市場ダイナミクス
- DTPワクチンの業界動向
- DTPワクチン市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Highlights
The global DTP Vaccine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for DTP Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for DTP Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of DTP Vaccine include SANOFI PASTEUR, NOVARTIS, Vaxelis, GSK, Serum Institute of India, Johnson & Johnson, Merck Sharp & Dohme Corp, Seqirus and Pfizer, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for DTP Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DTP Vaccine.
The DTP Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global DTP Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DTP Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
SANOFI PASTEUR
NOVARTIS
Vaxelis
GSK
Serum Institute of India
Johnson & Johnson
Merck Sharp & Dohme Corp
Seqirus
Pfizer
Astrazeneca
astellas
Emergent BioSolutions Inc
WALVAX
Wuhan Institute of Biological Products Co.,Ltd.
Chengdu Institute of Biological Products Co.,Ltd.
Segment by Type
Pertussis
Diphtheria
Tetanus
Segment by Application
Hospital
Epidemic Prevention Station
Village Health Room
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of DTP Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of DTP Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 DTP Vaccine Market Overview
1.1 Product Overview and Scope of DTP Vaccine
1.2 DTP Vaccine Segment by Type
1.2.1 Global DTP Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Pertussis
1.2.3 Diphtheria
1.2.4 Tetanus
1.3 DTP Vaccine Segment by Application
1.3.1 Global DTP Vaccine Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Epidemic Prevention Station
1.3.4 Village Health Room
1.4 Global DTP Vaccine Market Size Estimates and Forecasts
1.4.1 Global DTP Vaccine Revenue 2018-2029
1.4.2 Global DTP Vaccine Sales 2018-2029
1.4.3 Global DTP Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 DTP Vaccine Market Competition by Manufacturers
2.1 Global DTP Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global DTP Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global DTP Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global DTP Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of DTP Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of DTP Vaccine, Product Type & Application
2.7 DTP Vaccine Market Competitive Situation and Trends
2.7.1 DTP Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest DTP Vaccine Players Market Share by Revenue
2.7.3 Global DTP Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 DTP Vaccine Retrospective Market Scenario by Region
3.1 Global DTP Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global DTP Vaccine Global DTP Vaccine Sales by Region: 2018-2029
3.2.1 Global DTP Vaccine Sales by Region: 2018-2023
3.2.2 Global DTP Vaccine Sales by Region: 2024-2029
3.3 Global DTP Vaccine Global DTP Vaccine Revenue by Region: 2018-2029
3.3.1 Global DTP Vaccine Revenue by Region: 2018-2023
3.3.2 Global DTP Vaccine Revenue by Region: 2024-2029
3.4 North America DTP Vaccine Market Facts & Figures by Country
3.4.1 North America DTP Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America DTP Vaccine Sales by Country (2018-2029)
3.4.3 North America DTP Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe DTP Vaccine Market Facts & Figures by Country
3.5.1 Europe DTP Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe DTP Vaccine Sales by Country (2018-2029)
3.5.3 Europe DTP Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific DTP Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific DTP Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific DTP Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific DTP Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America DTP Vaccine Market Facts & Figures by Country
3.7.1 Latin America DTP Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America DTP Vaccine Sales by Country (2018-2029)
3.7.3 Latin America DTP Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa DTP Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa DTP Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa DTP Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa DTP Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global DTP Vaccine Sales by Type (2018-2029)
4.1.1 Global DTP Vaccine Sales by Type (2018-2023)
4.1.2 Global DTP Vaccine Sales by Type (2024-2029)
4.1.3 Global DTP Vaccine Sales Market Share by Type (2018-2029)
4.2 Global DTP Vaccine Revenue by Type (2018-2029)
4.2.1 Global DTP Vaccine Revenue by Type (2018-2023)
4.2.2 Global DTP Vaccine Revenue by Type (2024-2029)
4.2.3 Global DTP Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global DTP Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global DTP Vaccine Sales by Application (2018-2029)
5.1.1 Global DTP Vaccine Sales by Application (2018-2023)
5.1.2 Global DTP Vaccine Sales by Application (2024-2029)
5.1.3 Global DTP Vaccine Sales Market Share by Application (2018-2029)
5.2 Global DTP Vaccine Revenue by Application (2018-2029)
5.2.1 Global DTP Vaccine Revenue by Application (2018-2023)
5.2.2 Global DTP Vaccine Revenue by Application (2024-2029)
5.2.3 Global DTP Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global DTP Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 SANOFI PASTEUR
6.1.1 SANOFI PASTEUR Corporation Information
6.1.2 SANOFI PASTEUR Description and Business Overview
6.1.3 SANOFI PASTEUR DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 SANOFI PASTEUR DTP Vaccine Product Portfolio
6.1.5 SANOFI PASTEUR Recent Developments/Updates
6.2 NOVARTIS
6.2.1 NOVARTIS Corporation Information
6.2.2 NOVARTIS Description and Business Overview
6.2.3 NOVARTIS DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 NOVARTIS DTP Vaccine Product Portfolio
6.2.5 NOVARTIS Recent Developments/Updates
6.3 Vaxelis
6.3.1 Vaxelis Corporation Information
6.3.2 Vaxelis Description and Business Overview
6.3.3 Vaxelis DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Vaxelis DTP Vaccine Product Portfolio
6.3.5 Vaxelis Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GSK DTP Vaccine Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Corporation Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Serum Institute of India DTP Vaccine Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Johnson & Johnson DTP Vaccine Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Merck Sharp & Dohme Corp
6.6.1 Merck Sharp & Dohme Corp Corporation Information
6.6.2 Merck Sharp & Dohme Corp Description and Business Overview
6.6.3 Merck Sharp & Dohme Corp DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck Sharp & Dohme Corp DTP Vaccine Product Portfolio
6.7.5 Merck Sharp & Dohme Corp Recent Developments/Updates
6.8 Seqirus
6.8.1 Seqirus Corporation Information
6.8.2 Seqirus Description and Business Overview
6.8.3 Seqirus DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Seqirus DTP Vaccine Product Portfolio
6.8.5 Seqirus Recent Developments/Updates
6.9 Pfizer
6.9.1 Pfizer Corporation Information
6.9.2 Pfizer Description and Business Overview
6.9.3 Pfizer DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Pfizer DTP Vaccine Product Portfolio
6.9.5 Pfizer Recent Developments/Updates
6.10 Astrazeneca
6.10.1 Astrazeneca Corporation Information
6.10.2 Astrazeneca Description and Business Overview
6.10.3 Astrazeneca DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Astrazeneca DTP Vaccine Product Portfolio
6.10.5 Astrazeneca Recent Developments/Updates
6.11 astellas
6.11.1 astellas Corporation Information
6.11.2 astellas DTP Vaccine Description and Business Overview
6.11.3 astellas DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 astellas DTP Vaccine Product Portfolio
6.11.5 astellas Recent Developments/Updates
6.12 Emergent BioSolutions Inc
6.12.1 Emergent BioSolutions Inc Corporation Information
6.12.2 Emergent BioSolutions Inc DTP Vaccine Description and Business Overview
6.12.3 Emergent BioSolutions Inc DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Emergent BioSolutions Inc DTP Vaccine Product Portfolio
6.12.5 Emergent BioSolutions Inc Recent Developments/Updates
6.13 WALVAX
6.13.1 WALVAX Corporation Information
6.13.2 WALVAX DTP Vaccine Description and Business Overview
6.13.3 WALVAX DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 WALVAX DTP Vaccine Product Portfolio
6.13.5 WALVAX Recent Developments/Updates
6.14 Wuhan Institute of Biological Products Co.,Ltd.
6.14.1 Wuhan Institute of Biological Products Co.,Ltd. Corporation Information
6.14.2 Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Description and Business Overview
6.14.3 Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Product Portfolio
6.14.5 Wuhan Institute of Biological Products Co.,Ltd. Recent Developments/Updates
6.15 Chengdu Institute of Biological Products Co.,Ltd.
6.15.1 Chengdu Institute of Biological Products Co.,Ltd. Corporation Information
6.15.2 Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Description and Business Overview
6.15.3 Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Product Portfolio
6.15.5 Chengdu Institute of Biological Products Co.,Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 DTP Vaccine Industry Chain Analysis
7.2 DTP Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 DTP Vaccine Production Mode & Process
7.4 DTP Vaccine Sales and Marketing
7.4.1 DTP Vaccine Sales Channels
7.4.2 DTP Vaccine Distributors
7.5 DTP Vaccine Customers
8 DTP Vaccine Market Dynamics
8.1 DTP Vaccine Industry Trends
8.2 DTP Vaccine Market Drivers
8.3 DTP Vaccine Market Challenges
8.4 DTP Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ DTPワクチンのグローバル市場2023年：百日咳、ジフテリア、破傷風(Global DTP Vaccine Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ジフテリア/破傷風/百日咳（DPT）ワクチンの世界市場見通し2023年-2029年
  • 結核病ワクチンのグローバル市場2023年：予防ワクチン、曝露後ワクチン、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆